These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26809868)

  • 1. Treatment of Crohn's Disease with an IgG4-Guided Exclusion Diet: A Randomized Controlled Trial.
    Gunasekeera V; Mendall MA; Chan D; Kumar D
    Dig Dis Sci; 2016 Apr; 61(4):1148-57. PubMed ID: 26809868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Food-specific IgG4-guided exclusion diets improve symptoms in Crohn's disease: a pilot study.
    Rajendran N; Kumar D
    Colorectal Dis; 2011 Sep; 13(9):1009-13. PubMed ID: 20626437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food-specific IgG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome.
    Zar S; Mincher L; Benson MJ; Kumar D
    Scand J Gastroenterol; 2005 Jul; 40(7):800-7. PubMed ID: 16109655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of provocation by foods with raised IgG antibodies and additives on the course of Crohn's disease: a pilot study.
    Uzunısmaıl H; Cengız M; Uzun H; Ozbakir F; Göksel S; Demırdağ F; Can G; Balci H
    Turk J Gastroenterol; 2012 Feb; 23(1):19-27. PubMed ID: 22505375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of food antigen test in the diagnosis of Crohn's disease and remission maintenance after exclusive enteral nutrition.
    Wang G; Ren J; Li G; Hu Q; Gu G; Ren H; Hong Z; Li J
    Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):145-152. PubMed ID: 29102418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.
    Forbes GM; Sturm MJ; Leong RW; Sparrow MP; Segarajasingam D; Cummins AG; Phillips M; Herrmann RP
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):64-71. PubMed ID: 23872668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin G4-related immune responses to common food antigens in patients with ulcerative colitis and Crohn's disease.
    Sub Lee H; Jae Lee K
    Turk J Gastroenterol; 2019 May; 30(5):408–414. PubMed ID: 31060995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREATMENT OF ANEMIA AND IMPROVEMENT OF QUALITY OF LIFE AMONG PATIENTS WITH CROHN'S DISEASE: experience using ferric carboxymaltose.
    Sobrado CW; Cançado RD; Sobrado LF; Frugis MO; Sobrado MF
    Arq Gastroenterol; 2015 Dec; 52(4):255-9. PubMed ID: 26840464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of IgG antibodies against food antigens in Crohn's disease: a double-blind cross-over diet intervention study.
    Bentz S; Hausmann M; Piberger H; Kellermeier S; Paul S; Held L; Falk W; Obermeier F; Fried M; Schölmerich J; Rogler G
    Digestion; 2010; 81(4):252-64. PubMed ID: 20130407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgically-relevant quality of life thresholds for the Short Inflammatory Bowel Disease Questionnaire in Crohn's disease.
    Ueland TE; Horst SN; Shroder MM; Ye F; Bai K; McCoy AB; Bachmann JM; Hawkins AT
    J Gastrointest Surg; 2024 Aug; 28(8):1265-1272. PubMed ID: 38815800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ingested matter affects intestinal lesions in Crohn's disease.
    Bartel G; Weiss I; Turetschek K; Schima W; Püspök A; Waldhoer T; Gasche C
    Inflamm Bowel Dis; 2008 Mar; 14(3):374-82. PubMed ID: 17932967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.
    Colombel JF; Sandborn WJ; Rutgeerts P; Kamm MA; Yu AP; Wu EQ; Pollack PF; Lomax KG; Chao J; Mulani PM
    Am J Gastroenterol; 2009 May; 104(5):1170-9. PubMed ID: 19352339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn's disease.
    Lomer MC; Grainger SL; Ede R; Catterall AP; Greenfield SM; Cowan RE; Vicary FR; Jenkins AP; Fidler H; Harvey RS; Ellis R; McNair A; Ainley CC; Thompson RP; Powell JJ
    Eur J Gastroenterol Hepatol; 2005 Mar; 17(3):377-84. PubMed ID: 15716665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.
    Irvine EJ; Zhou Q; Thompson AK
    Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food-specific serum IgG4 and IgE titers to common food antigens in irritable bowel syndrome.
    Zar S; Benson MJ; Kumar D
    Am J Gastroenterol; 2005 Jul; 100(7):1550-7. PubMed ID: 15984980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary intake of inulin-type fructans in active and inactive Crohn's disease and healthy controls: a case-control study.
    Anderson JL; Hedin CR; Benjamin JL; Koutsoumpas A; Ng SC; Hart AL; Forbes A; Stagg AJ; Lindsay JO; Whelan K
    J Crohns Colitis; 2015 Nov; 9(11):1024-31. PubMed ID: 26221003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Crohn's Disease Exclusion Diet for Induction of Remission in Crohn's Disease Adult Patients.
    Szczubełek M; Pomorska K; Korólczyk-Kowalczyk M; Lewandowski K; Kaniewska M; Rydzewska G
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Turunen U; Arkkila P; Sipponen T; Färkkilä M
    Scand J Gastroenterol; 2012 May; 47(5):528-37. PubMed ID: 22356594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.